marginally significantP =0.05
Patients with stage-IV disease were associated with a marginally significant elevated expression of Lin28B compared with stage I–III patients ( P =0.05, one-way ANOVA).
Patients with stage-IV disease were associated with a marginally significant elevated expression of Lin28B compared with stage I–III patients ( P =0.05, one-way ANOVA).